Combination Immunotherapy May Further Increase Melanoma Survival Length
Elisa Becze, BA, ELS, Editor
Voice
Description
Using two agents that target two different receptors more than doubles length of survival for advanced melanoma than a single agent alone, researchers reported at the 2021 American Society of Clinical Oncology annual meeting.